A novel neural circuit analysis paradigm to model autism in mice
一种新颖的神经回路分析范例来模拟小鼠自闭症
基本信息
- 批准号:8747757
- 负责人:
- 金额:$ 19.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsAreaAutistic DisorderBehaviorBehavioralBiological MarkersBiological Neural NetworksBrainBrain regionCollectionCommunicationDeep Brain StimulationDefectDevelopmentDiseaseDisease modelDistalElectrodesElectroencephalographyEnvironmental Risk FactorExhibitsExonsExperimental DesignsExploratory/Developmental GrantFaceFrequenciesFunctional Magnetic Resonance ImagingFunctional disorderGenerationsGenesGeneticGoalsGroomingHeterogeneityHippocampus (Brain)HumanKnowledgeLeadLearningLinkMagnetoencephalographyMethodsModelingMolecularMolecular TargetMusMutant Strains MiceMutationPacemakersPathogenesisPathway interactionsPharmaceutical PreparationsPhysiologyPositron-Emission TomographyPrefrontal CortexProcessResearchResearch PersonnelRodentSeriesSliceSocial BehaviorSocial InteractionSynapsesTechniquesTimeTranscranial magnetic stimulationValidationautism spectrum disorderautistic behaviourbasebehavioral impairmentclinical Diagnosiseffective therapyelectrical measurementendophenotypegene functionhigh rewardhigh riskin vivoinsightmillisecondmouse modelneural circuitneurophysiologyneuropsychiatrynovelpublic health relevancerelating to nervous systemrepairedresearch studyskillssocialstemtrait
项目摘要
A Novel Neural Circuit Analysis Paradigm to Model Autism in Mice
The circuit defects underlying the behavioral impairments of autism spectrum disorders (ASD) remains poorly
understood. This knowledge is critical for development of effective treatments. The considerable molecular
heterogeneity in human ASD and the apparent limitations in human studies renders mutant mice with targeted
mutations equivalent to humans a unique opportunity because it allows manipulation at both molecular and
circuit levels. There is an increasing list of ASD models with both "construct" (molecular defect mimics human
ASD) and "face" (behavioral impairments equivalent to core feature of human ASD) validity. The current
analytic paradigm of modeling human ASD in mutant mice focuses on analyzing synaptic development and
function using slice physiology and behavior analysis. These studies have produced evidence supporting a
general conclusion of synaptic dysfunction in ASD models. However, these findings offer little insight into the
circuit mechanism underlying behavioral impairments because the findings from studying the synapses in
select brain regions are frequently variable and inconsistent among different studies. The fundamental
challenge of ASD research lies within the complexity of understanding how alterations in gene function disrupt
large scale brain networks responsible for normal functional process underlying autistic behaviors. For these
reasons, the field of modeling human ASD in genetically modified mutant mice demands a new analytic
paradigm to dissect the dysfunction at circuit or network levels. We have developed a novel multi-unit in vivo
recoding technique that can acquire neural activity from as many as 11 brain regions in free moving animals
simultaneously. This novel technique offers a feasibility to detect dysfunctional neural circuit and network. We
have also produced and characterized unique Shank2 exon 24 (Shank3e24) and Shank3 exon 4-22 (Shank3e4-
22) deletion mutant mice that have strong construct and face validity for human ASD. These mutant mice
provide unique opportunities to develop a novel analytic paradigm for dissecting circuit dysfunction. The long
term goal of this project is to define dysfunctional circuit underlying ASD behaviors using ASD mouse models.
The central hypothesis is dysfunction synchrony across distinct relevant neural circuits will be observed in
Shank3e4-22 and Shank2e24 mutant mice. The specific objective is to identify the dysfunctional neural circuits
underlying social deficits and repetitive behaviors in these mutant mice using a novel in vivo multiple-unit
recording technique pioneered by our team. These experiments will lead to the identification of
electrophysiological biomarkers of endophenotypes that will aid in the validation of novel molecular targets for
novel neuropsychiatric drugs, enhance the targeting of current neuromodulatory therapies for use in ASD and
facilitate the development of closed loop neuromodulatory "pacemakers" which directly repair the dysfunctional
brain circuits underlying the behavioral manifestations in ASD. These findings will address a significant gap in
our knowledge and provide evidence to support a paradigm shift in modeling human ASD using mutant mice.
一种新的神经回路分析范式来模拟小鼠自闭症
自闭症谱系障碍 (ASD) 行为障碍背后的回路缺陷仍然很差
明白了。这些知识对于开发有效的治疗方法至关重要。相当大的分子
人类 ASD 的异质性和人类研究的明显局限性使得突变小鼠具有针对性
相当于人类的突变是一个独特的机会,因为它允许在分子和
电路电平。越来越多的 ASD 模型同时具有“结构”(分子缺陷模仿人类)
ASD)和“面子”(相当于人类 ASD 核心特征的行为障碍)有效性。目前的
在突变小鼠中模拟人类 ASD 的分析范式侧重于分析突触发育和
使用切片生理学和行为分析的功能。这些研究提供了证据支持
ASD 模型中突触功能障碍的一般结论。然而,这些发现并没有让我们深入了解
行为障碍背后的电路机制,因为研究突触的结果
在不同的研究中,选定的大脑区域经常变化且不一致。基本的
自闭症谱系障碍研究的挑战在于理解基因功能的改变如何破坏的复杂性
负责自闭症行为背后的正常功能过程的大规模大脑网络。对于这些
由于这些原因,在转基因突变小鼠中模拟人类自闭症谱系障碍需要一种新的分析方法
剖析电路或网络级别功能障碍的范例。我们开发了一种新型体内多单元
重新编码技术可以获取自由活动动物多达 11 个大脑区域的神经活动
同时地。这项新技术提供了检测功能失调的神经回路和网络的可行性。我们
还产生并表征了独特的 Shank2 外显子 24 (Shank3e24) 和 Shank3 外显子 4-22 (Shank3e4-
22) 缺失突变小鼠,具有强大的结构并且对人类自闭症谱系障碍有效。这些突变小鼠
为开发一种用于剖析电路功能障碍的新颖分析范式提供了独特的机会。长的
该项目的长期目标是使用 ASD 小鼠模型定义 ASD 行为背后的功能失调电路。
中心假设是不同相关神经回路之间的同步功能障碍将在
Shank3e4-22 和 Shank2e24 突变小鼠。具体目标是识别功能失调的神经回路
使用新型体内多单元研究这些突变小鼠潜在的社交缺陷和重复行为
我们团队首创的录音技术。这些实验将导致鉴定
内表型的电生理生物标志物将有助于验证新的分子靶标
新型神经精神药物,增强当前神经调节疗法用于自闭症谱系障碍(ASD)和
促进闭环神经调节“起搏器”的发展,直接修复功能失调的
自闭症谱系障碍行为表现背后的大脑回路。这些发现将解决以下方面的重大差距:
我们的知识并提供证据支持使用突变小鼠模拟人类自闭症谱系障碍的范式转变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YONG-HUI JIANG其他文献
YONG-HUI JIANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YONG-HUI JIANG', 18)}}的其他基金
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models
Shank3小鼠模型中自闭症行为的分子和电路机制
- 批准号:
10326806 - 财政年份:2019
- 资助金额:
$ 19.67万 - 项目类别:
Epigenetic Therapy and Prader-Willi Syndrome
表观遗传疗法和普瑞德威利综合征
- 批准号:
10041371 - 财政年份:2019
- 资助金额:
$ 19.67万 - 项目类别:
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models
Shank3小鼠模型中自闭症行为的分子和电路机制
- 批准号:
10094257 - 财政年份:2019
- 资助金额:
$ 19.67万 - 项目类别:
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models
Shank3小鼠模型中自闭症行为的分子和电路机制
- 批准号:
9765845 - 财政年份:2019
- 资助金额:
$ 19.67万 - 项目类别:
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models
Shank3小鼠模型中自闭症行为的分子和电路机制
- 批准号:
10533806 - 财政年份:2019
- 资助金额:
$ 19.67万 - 项目类别:
Epigenetic Therapy and Prader-Willi Syndrome
表观遗传疗法和普瑞德威利综合征
- 批准号:
10171492 - 财政年份:2019
- 资助金额:
$ 19.67万 - 项目类别:
A novel paradigm to dissect the function connectivity in Shank3 autism model
剖析 Shank3 自闭症模型中功能连接的新范式
- 批准号:
9244943 - 财政年份:2017
- 资助金额:
$ 19.67万 - 项目类别:
Therapeutic potential for Prader-Willi syndrome
普瑞德威利综合征的治疗潜力
- 批准号:
8860216 - 财政年份:2014
- 资助金额:
$ 19.67万 - 项目类别:
Therapeutic potential for Prader-Willi syndrome
普瑞德威利综合征的治疗潜力
- 批准号:
8702324 - 财政年份:2014
- 资助金额:
$ 19.67万 - 项目类别:
A novel neural circuit analysis paradigm to model autism in mice
一种新颖的神经回路分析范例来模拟小鼠自闭症
- 批准号:
8917303 - 财政年份:2014
- 资助金额:
$ 19.67万 - 项目类别:
相似国自然基金
臂旁核区域损伤致长时程“昏迷样”动物模型建立及神经机制研究
- 批准号:81901068
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
三江源大型野生食草动物对区域草畜平衡状态影响及管控机制研究
- 批准号:41971276
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
基于组蛋白H3K9me3和DNA甲基化修饰协同作用研究早期胚胎发育过程中基因印记区域的调控
- 批准号:31801059
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
转录因子Msx1与哺乳动物上腭发育的前-后区域化
- 批准号:31771593
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
家鸽对城市区域大气重金属污染物的暴露响应研究
- 批准号:41701574
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 19.67万 - 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 19.67万 - 项目类别:
Feasibility of Using PET Imaging for Detection of Treatment-Induced Changes in Chronic Neuroinflammation Following TBI
使用 PET 成像检测 TBI 后治疗引起的慢性神经炎症变化的可行性
- 批准号:
10703823 - 财政年份:2023
- 资助金额:
$ 19.67万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 19.67万 - 项目类别: